glycidyl nitrate has been researched along with Sepsis in 49 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 11 (22.45) | 18.7374 |
1990's | 2 (4.08) | 18.2507 |
2000's | 16 (32.65) | 29.6817 |
2010's | 15 (30.61) | 24.3611 |
2020's | 5 (10.20) | 2.80 |
Authors | Studies |
---|---|
Coggeshall, KM; Keshari, RS; Lupu, C; Lupu, F; Popescu, NI; Regmi, G; Ricardo, A; Silasi, R; Simmons, JH | 1 |
Al-Janabi, F; Bird, MF; Calo, G; Gallacher-Horley, B; Guerrini, R; Lambert, DG; McDonald, J; McVey, DG; Thompson, JP; Ye, S | 1 |
Cafiso, V; Cialfi, A; Lo Verde, F; Stefani, S; Stracquadanio, S; Zega, A | 1 |
Bauer, M; Cheng, S; Gallardo, L; Hellman, J; Jackson, N; Konovalova, A; McNamara, C; Michel, LV; Pichichero, ME; Pierce, J; Snyder, E; Zavorin, M | 1 |
Ioanna, Z; Irene, A; Katerina, B | 1 |
Gisch, N; Gómez-Mejia, A; Hain, T; Hammerschmidt, S; Heß, N; Kohler, TP; Kreikemeyer, B; Rohde, M; Schwudke, D; Vollmer, W; Waldow, F | 1 |
Lee, JC; Thompson, CD; Wang, X; Weidenmaier, C | 1 |
Ali, A; Boldock, E; Dockrell, DH; Fei, Y; Foster, SJ; Jin, T; Kubes, P; McCoy, KD; Morris, P; Na, M; Pollitt, EJG; Prajsnar, TK; Renshaw, SA; Shamarina, D; Surewaard, BGJ; Szkuta, P; van Strijp, JAG; Williams, A | 1 |
Choi, J; Guk, K; Jung, J; Kang, T; Lee, DK; Lim, EK; Lim, J; Son, SU; Yeom, SJ | 1 |
Guo, Z; Ji, G; Li, P; Li, Y; Luo, B; Song, H; Wang, Y; Xu, L; Yang, M; Yang, Y; Yu, Y; Zhang, Y; Zheng, A; Zheng, Y | 1 |
Coldewey, SM; Collino, M; Patel, NS; Rogazzo, M; Thiemermann, C | 1 |
Chen, J; Chiazza, F; Coldewey, SM; Collino, M; Patel, NS; Thiemermann, C | 1 |
Appaiah, C; Bhatt, RN; Chikkamadaiah, R; Desai, S; Durgaiah, M; Nair, S; Narasimhaswamy, N; Padmanabhan, S; Poonacha, N; Raghupatil, J; Roy, P; Saravanan, S; Sharma, U; Sriram, B; Sundarrajan, S; Vipra, A | 1 |
Alexander, C; Bárcena-Varela, S; Brandenburg, K; Correa, W; Ferrer-Espada, R; Fukuoka, S; Gisch, N; Goldmann, T; Gutsmann, T; Heinbockel, L; Heine, H; Martinez de Tejada, G; Sánchez-Gómez, S; Schürholz, T; Wiesmüller, KH | 1 |
Bauer, M; Benetti, E; Coldewey, SM; Collino, M; Huwiler, A; Pfeilschifter, J; Sponholz, C; Thiemermann, C | 1 |
Lee, JY; Lin, K; Linge, HM; Miller, EJ; Ochani, K | 2 |
Andrade, ASR; Cardoso, J; Graziani, AC; Krieger, MA; Lopes, ALK; Marton, S; Mendes, IF; Schluga, PHC; Stets, MI | 1 |
Galley, HF; Lowes, DA; Murphy, MP; Thottakam, BM; Webster, NR | 1 |
Gao, X; Ha, T; Hu, Y; Hua, F; Kalbfleisch, J; Kao, RL; Kelley, J; Li, C; Liu, L; Lu, C; Singh, K; Williams, DL | 1 |
Ballard, JL; Coggeshall, KM; Iyer, JK; James, JA; Langer, M; Metcalf, J; Raisley, B; Sun, D; Vedham, V | 1 |
Aasen, AO; Dahle, MK; Foster, SJ; McDonald, M; Thiemermann, C; Wang, JE | 1 |
Grandel, U; Grimminger, F | 1 |
Zingarelli, B | 1 |
Bagchi, A; Beasley-Topliffe, LK; Fenton, MJ; Hellman, J; Lazzaroni, JC; Liang, MD; Tehan, MM; Tesini, BL; Trigilio, JA; Warren, HS | 1 |
Endo, Y; Hanasawa, K; Mori, T; Shimizu, T; Tabata, T; Tani, T; Tsuchiya, M | 1 |
Aasen, AO; Myhre, AE; Wang, JE | 1 |
Aasen, AO; Myhre, AE; Thiemermann, C; Wang, JE | 1 |
Allen, DA; Collin, M; Dugo, L; Foster, SJ; Murch, O; Thiemermann, C; Yaqoob, MM | 1 |
Aasen, AO; Wang, JE | 1 |
Allen, DA; Bauer, I; Collin, M; Dugo, L; Foster, SJ; Louhelainen, M; Mervaala, E; Patel, NS; Thiemermann, C; Yaqoob, MM | 1 |
Peterson, PK; Verbrugh, HA; Verhoef, J; Wilkinson, BJ | 1 |
Aasjord, P; Endresen, C; Natås, O; Oeding, P; Wergeland, H | 1 |
Christensson, B; Hedström, SA; Kronvall, G | 1 |
Jaspers, FC; Musher, DM; Spika, JS; Verbrugh, HA; Verhoef, J | 1 |
Nelson, RD; Peterson, PK; Thompson, RL; Verbrugh, HA; Wilkinson, BJ | 1 |
Christensson, B; Espersen, F; Hedström, SA; Kronvall, G | 2 |
Atherton, FR; Hall, MJ; Hassall, CH; Lambert, RW; Lloyd, WJ; Ringrose, PS; Westmacott, D | 1 |
Hammerschmidt, DE; Peterson, PK; Quie, PG; Spika, JS; Verbrugh, HA; Verhoef, J; Wilkinson, BJ | 1 |
Sheagren, JN; Tuazon, CU; Zeiger, AR | 1 |
Cohen, J; Sriskandan, S | 1 |
Alving, K; Middelveld, RJ | 1 |
Horn, DL; Morrison, DC; Opal, SM; Silverstein, R; Visvanathan, K; Zabriskie, JB | 1 |
Beutler, B; Poltorak, A | 1 |
Aasen, AO; Almiöf, M; Ellingsen, EA; Foster, SJ; Jørgensen, PF; Solberg, R; Thiemermann, C; Wang, JE | 1 |
Allaire, JE; Hellman, J; Roberts, JD; Tehan, MM; Warren, HS | 1 |
Kessler, CM; Nussbaum, E; Tuazon, CU | 1 |
Goessens, WH; Michel, MF; Peters, R; Verbrugh, HA | 1 |
7 review(s) available for glycidyl nitrate and Sepsis
Article | Year |
---|---|
Peptidoglycan and lipoteichoic acid in gram-positive bacterial sepsis: receptors, signal transduction, biological effects, and synergism.
Topics: Animals; Cell Wall; Cytokines; Drug Synergism; Endotoxins; Humans; Lipopolysaccharides; Models, Biological; Peptidoglycan; Receptors, Cell Surface; Sepsis; Signal Transduction; Teichoic Acids | 2003 |
Endothelial responses to bacterial toxins in sepsis.
Topics: Animals; Bacterial Toxins; Endothelium, Vascular; Endotoxins; Exotoxins; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Lipopolysaccharides; Models, Biological; Multiple Organ Failure; Peptidoglycan; Sepsis; Teichoic Acids | 2003 |
Peptidoglycan--an endotoxin in its own right?
Topics: Endotoxins; Gene Expression Regulation; Humans; Inflammation; Lymphocyte Activation; Multiple Organ Failure; Peptidoglycan; Sepsis; Signal Transduction | 2006 |
Mediator responses in surgical infections.
Topics: Animals; Cytokines; Dogs; Humans; Lipopolysaccharides; Multiple Organ Failure; Peptidoglycan; Rats; Sepsis; Staphylococcal Infections; Staphylococcus aureus; Surgical Wound Infection | 2006 |
Gram-positive sepsis. Mechanisms and differences from gram-negative sepsis.
Topics: Animals; Bacterial Proteins; Bacterial Toxins; Carbohydrate Metabolism; Cell Wall; Enterotoxins; Exotoxins; Gram-Positive Bacterial Infections; Humans; Membrane Proteins; Peptidoglycan; Sepsis; Superantigens; Teichoic Acids; Tumor Necrosis Factor-alpha | 1999 |
What are the microbial components implicated in the pathogenesis of sepsis? Report on a symposium.
Topics: Amino Acid Sequence; Animals; Carbohydrate Sequence; Disease Models, Animal; DNA, Bacterial; Endotoxins; Gram-Positive Bacteria; Humans; Inflammation Mediators; Lipid A; Models, Biological; Peptidoglycan; Sepsis | 2000 |
Sepsis and evolution of the innate immune response.
Topics: Animals; Antibodies; Antigens, Surface; Biological Evolution; DNA, Bacterial; Drosophila Proteins; Genetic Variation; Humans; Lymphocyte Antigen 96; Lymphocytes; Macrophages; Membrane Glycoproteins; Peptidoglycan; Plants; Receptors, Cell Surface; Sepsis; Shock, Septic; Signal Transduction; Toll-Like Receptor 2; Toll-Like Receptor 4; Toll-Like Receptor 9; Toll-Like Receptors | 2001 |
42 other study(ies) available for glycidyl nitrate and Sepsis
Article | Year |
---|---|
Complement C5 inhibition protects against hemolytic anemia and acute kidney injury in anthrax peptidoglycan-induced sepsis in baboons.
Topics: Acute Kidney Injury; Anemia, Hemolytic; Animals; Anthrax; Bacillus anthracis; Cell Wall; Complement C5; Female; Hemolysis; Male; Papio; Peptidoglycan; Sepsis | 2021 |
In vitro sepsis induces Nociceptin/Orphanin FQ receptor (NOP) expression in primary human vascular endothelial but not smooth muscle cells.
Topics: Animals; Endothelial Cells; Humans; Hypotension; Lipopolysaccharides; Muscle Cells; Nociceptin; Nociceptin Receptor; Opioid Peptides; Peptidoglycan; Receptors, Opioid; RNA, Messenger; Sepsis | 2022 |
Titration of Igs contained in an intravenous IgM-enriched preparation against selected pathogens involved in sepsis.
Topics: Anti-Bacterial Agents; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Immunoglobulin A; Immunoglobulin M; Immunoglobulins, Intravenous; Lipopolysaccharides; Peptidoglycan; Sepsis; Teichoic Acids | 2020 |
Ampicillin triggers the release of Pal in toxic vesicles from Escherichia coli.
Topics: Ampicillin; Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Escherichia coli; Escherichia coli Proteins; Gentamicins; Humans; Levofloxacin; Lipoproteins; Microbial Sensitivity Tests; Peptidoglycan; Sepsis | 2020 |
Immunotherapy-on-Chip Against an Experimental Sepsis Model.
Topics: Animals; Cytokines; Disease Models, Animal; Equipment Design; Female; Immunotherapy; Inflammation Mediators; Lipopolysaccharides; Macrophage Activation; Macrophages; Male; Mice, Inbred BALB C; Micrococcus; Peptidoglycan; Sepsis; Spleen; Surface Properties; T-Lymphocyte Subsets; Tissue Scaffolds | 2021 |
Lipoteichoic acid deficiency permits normal growth but impairs virulence of Streptococcus pneumoniae.
Topics: Animals; Cell Line; Cell Wall; Disease Models, Animal; Humans; Ligases; Lipopolysaccharides; Male; Mice; Microscopy, Electron; Mutagenesis; Peptidoglycan; Pneumonia, Pneumococcal; Sepsis; Streptococcus pneumoniae; Teichoic Acids; Virulence | 2017 |
Release of Staphylococcus aureus extracellular vesicles and their application as a vaccine platform.
Topics: Animals; Antibodies, Neutralizing; Cell Wall; Cytotoxins; Extracellular Vesicles; Female; Genetic Engineering; Methicillin-Resistant Staphylococcus aureus; Mice; Peptidoglycan; Sepsis; Staphylococcal Infections; Staphylococcal Vaccines; Survival Analysis; Vaccination | 2018 |
Human skin commensals augment Staphylococcus aureus pathogenesis.
Topics: Animals; Bacteria; Disease Models, Animal; Humans; Inflammasomes; Kupffer Cells; Macrophages; Mice; Microbiota; Peptidoglycan; Reactive Oxygen Species; Sepsis; Skin; Staphylococcal Infections; Staphylococcus aureus; Symbiosis; Virulence | 2018 |
Peptidoglycan binding protein (PGBP)-modified magnetic nanobeads for efficient magnetic capturing of Staphylococcus aureus associated with sepsis in blood.
Topics: Bacterial Proteins; Carrier Proteins; Gram-Positive Bacteria; Humans; Immunomagnetic Separation; Peptidoglycan; Protein Binding; Sepsis; Staphylococcus aureus | 2019 |
Ephedrine hydrochloride inhibits PGN-induced inflammatory responses by promoting IL-10 production and decreasing proinflammatory cytokine secretion via the PI3K/Akt/GSK3β pathway.
Topics: Animals; Anti-Inflammatory Agents; Cell Line; Cytokines; Disease Models, Animal; Ephedrine; Female; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Inflammation Mediators; Interleukin-10; Macrophages, Peritoneal; Mice; Mice, Inbred C57BL; Peptidoglycan; Peritonitis; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Sepsis; Signal Transduction | 2013 |
Inhibition of IκB kinase reduces the multiple organ dysfunction caused by sepsis in the mouse.
Topics: Animals; Cecum; Heart Function Tests; I-kappa B Kinase; I-kappa B Proteins; Kidney; Ligation; Lipopolysaccharides; Liver; Male; Mice; Mice, Inbred C57BL; Multiple Organ Failure; Myocardium; NF-KappaB Inhibitor alpha; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Peptidoglycan; Pneumonia; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Punctures; Sepsis; Signal Transduction; Transcription Factor RelA | 2013 |
Gender dimorphism of the cardiac dysfunction in murine sepsis: signalling mechanisms and age-dependency.
Topics: Age Factors; Animals; Female; Gene Expression Regulation; Heart Failure; Humans; I-kappa B Proteins; Interleukin-6; Lipopolysaccharides; Male; Mice; Mice, Inbred C57BL; NF-KappaB Inhibitor alpha; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Peptidoglycan; Phosphorylation; Proto-Oncogene Proteins c-akt; Sepsis; Sex Factors; Signal Transduction; Transcription Factor RelA; Tumor Necrosis Factor-alpha | 2014 |
Bacteriophage-derived CHAP domain protein, P128, kills Staphylococcus cells by cleaving interpeptide cross-bridge of peptidoglycan.
Topics: Animals; Anti-Bacterial Agents; Cell Wall; Disease Models, Animal; Drug Resistance, Bacterial; Peptide Hydrolases; Peptidoglycan; Recombinant Fusion Proteins; Sepsis; Staphylococcus; Staphylococcus Phages; Virulence | 2014 |
Lipoproteins/peptides are sepsis-inducing toxins from bacteria that can be neutralized by synthetic anti-endotoxin peptides.
Topics: Animals; Anti-Bacterial Agents; Cytokines; Disease Models, Animal; Endotoxemia; Endotoxins; Female; Gram-Negative Bacteria; HEK293 Cells; Humans; Leukocytes, Mononuclear; Lipopolysaccharides; Lipoproteins; Macrophages; Mice; Peptides; Peptidoglycan; Sepsis; Staphylococcus aureus; Teichoic Acids | 2015 |
Elevation of serum sphingosine-1-phosphate attenuates impaired cardiac function in experimental sepsis.
Topics: Animals; Cardiotonic Agents; Disease Models, Animal; Fingolimod Hydrochloride; Heart; Humans; Inflammation; Lipopolysaccharides; Lysophospholipids; Male; Mice; Mice, Inbred C57BL; Myocardial Contraction; Myocardium; Peptidoglycan; Phosphatidylinositol 3-Kinases; Phosphorylation; Pilot Projects; Receptors, Lysosphingolipid; Sepsis; Sphingosine | 2016 |
N-Ethylmaleimide Sensitive Factor (NSF) Inhibition Prevents Vascular Instability following Gram-Positive Pulmonary Challenge.
Topics: Angiopoietin-1; Animals; Bacterial Infections; Blood Vessels; Cell Line; Cell Wall; Cytoskeleton; Disease Models, Animal; Exocytosis; Gram-Positive Bacteria; Humans; Inflammation; Lipopolysaccharides; Lung; Male; Mice; Mice, Inbred BALB C; Microcirculation; N-Ethylmaleimide-Sensitive Proteins; Oxygen; Peptidoglycan; Phosphorylation; Pneumonia; Respiratory Distress Syndrome; Sepsis; Teichoic Acids; Vascular Diseases | 2016 |
Regulation of angiopoietin-2 secretion from human pulmonary microvascular endothelial cells.
Topics: Angiopoietin-2; Cell Wall; Cells, Cultured; Endothelial Cells; Gram-Positive Bacteria; Humans; Lipopolysaccharides; Lung; Peptidoglycan; Sepsis; Teichoic Acids | 2016 |
High Efficiency Binding Aptamers for a Wide Range of Bacterial Sepsis Agents.
Topics: Aptamers, Nucleotide; Bacteria; Biosensing Techniques; Cell Culture Techniques; DNA, Bacterial; DNA, Single-Stranded; Humans; Ligands; Molecular Diagnostic Techniques; Peptidoglycan; Real-Time Polymerase Chain Reaction; SELEX Aptamer Technique; Sensitivity and Specificity; Sepsis | 2017 |
The mitochondria-targeted antioxidant MitoQ protects against organ damage in a lipopolysaccharide-peptidoglycan model of sepsis.
Topics: Animals; Antioxidants; Cell Line; Creatinine; Cytokines; Disease Models, Animal; Endothelial Cells; Humans; Interleukin-10; Lipopolysaccharides; Membrane Potential, Mitochondrial; Mitochondria; Organophosphorus Compounds; Oxidative Stress; Peptidoglycan; Rats; Reactive Oxygen Species; Sepsis; Spectrometry, Fluorescence; Ubiquinone | 2008 |
TLR2 ligands attenuate cardiac dysfunction in polymicrobial sepsis via a phosphoinositide 3-kinase-dependent mechanism.
Topics: Animals; Cardiac Output; Disease Models, Animal; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Heart; Heart Diseases; Ligands; Lipopeptides; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Peptidoglycan; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Sepsis; Signal Transduction; Stroke Volume; Toll-Like Receptor 2 | 2010 |
Anti-peptidoglycan antibodies and Fcγ receptors are the key mediators of inflammation in Gram-positive sepsis.
Topics: Antibodies, Bacterial; Bacillus anthracis; Binding Sites; HEK293 Cells; Humans; Inflammation; Inflammation Mediators; Monocytes; Neutrophils; Peptidoglycan; Receptors, IgG; Sepsis; Staphylococcus aureus | 2012 |
Peptidoglycan is an important pathogenic factor of the inflammatory response in sepsis.
Topics: Humans; Inflammation; Peptidoglycan; Sepsis | 2004 |
Bacterial peptidoglycan-associated lipoprotein: a naturally occurring toll-like receptor 2 agonist that is shed into serum and has synergy with lipopolysaccharide.
Topics: Animals; Bacterial Outer Membrane Proteins; Cell Line; Drug Synergism; Escherichia coli; Escherichia coli K12; Escherichia coli Proteins; Humans; Lipopolysaccharides; Lipoproteins; Macrophage Activation; Macrophages, Peritoneal; Membrane Glycoproteins; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Knockout; Peptidoglycan; Receptors, Cell Surface; Sepsis; Toll-Like Receptor 2; Toll-Like Receptors | 2005 |
Diagnostic and predictive value of the silkworm larvae plasma test for postoperative infection following gastrointestinal surgery.
Topics: Aged; Biomarkers; C-Reactive Protein; Digestive System Surgical Procedures; Endotoxins; Female; Humans; Japan; Leukocyte Count; Male; Middle Aged; Multiple Organ Failure; Peptidoglycan; Postoperative Complications; Prospective Studies; Regression Analysis; Sensitivity and Specificity; Sepsis | 2005 |
Peptidoglycan: just another marker of postoperative infections or a mediator of disease?
Topics: Biomarkers; Humans; Multiple Organ Failure; Peptidoglycan; Postoperative Complications; Sepsis | 2005 |
Insulin reduces the multiple organ injury and dysfunction caused by coadministration of lipopolysaccharide and peptidoglycan independently of blood glucose: role of glycogen synthase kinase-3beta inhibition.
Topics: Analysis of Variance; Animals; Blood Glucose; Blood Pressure; Cells, Cultured; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Heart Rate; Hypoglycemic Agents; Inflammation; Insulin; Interleukin-1; Lipopolysaccharides; Male; Peptidoglycan; Prospective Studies; Random Allocation; Rats; Rats, Wistar; Sepsis; Systemic Inflammatory Response Syndrome; Thiadiazoles; Transcription Factor RelA | 2006 |
Inhibiting glycogen synthase kinase 3beta in sepsis.
Topics: Alanine Transaminase; Aminophenols; Animals; Aspartate Aminotransferases; Blotting, Western; Cells, Cultured; Creatinine; Endotoxemia; Enzyme Inhibitors; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Indoles; Interleukin-1beta; Kidney; Lipopolysaccharides; Male; Maleimides; Peptidoglycan; Phosphorylation; Rats; Rats, Wistar; Sepsis; Thiadiazoles; Transcription Factor RelA | 2007 |
Biology and clinical significance of peptidoglycan antibody response in staphylococcal infections.
Topics: Antibodies, Bacterial; Cross Reactions; Humans; Immunoglobulin G; Peptidoglycan; Sepsis; Staphylococcal Infections; Staphylococcus aureus | 1983 |
Antibodies to Staphylococcus aureus peptidoglycan and lipoteichoic acid in staphylococcal infections.
Topics: Antibodies, Bacterial; Endocarditis, Bacterial; Humans; Lipopolysaccharides; Osteomyelitis; Peptidoglycan; Phosphatidic Acids; Sepsis; Staphylococcal Infections; Staphylococcus aureus; Teichoic Acids | 1983 |
The clinical significance of serological methods in the diagnosis of staphylococcal septicaemia and endocarditis.
Topics: Antibodies, Bacterial; Antigens, Bacterial; Bacterial Toxins; Endocarditis, Bacterial; Hemolysin Proteins; Humans; Peptidoglycan; Radioimmunoassay; Sepsis; Staphylococcal Infections | 1983 |
The effect of staphylococcal peptidoglycan on polymorphonuclear leukocytes in vitro and in vivo.
Topics: Adult; Animals; Blood Pressure; Chemotaxis, Leukocyte; Complement Activation; Humans; Leukocyte Count; Male; Neutrophils; Peptidoglycan; Phagocytosis; Platelet Count; Rats; Rats, Inbred Strains; Sepsis; Staphylococcal Infections; Staphylococcus aureus | 1983 |
Serology of Staphylococcus aureus infections using multiple antigens and serial serum samples.
Topics: Antibodies, Bacterial; Bacterial Toxins; Enzyme-Linked Immunosorbent Assay; Hemolysin Proteins; Humans; Micrococcal Nuclease; Peptidoglycan; Sepsis; Staphylococcal Infections; Staphylococcus aureus; Teichoic Acids | 1983 |
Solid-phase radioimmunoassay of immunoglobulin G antibodies to Staphylococcus aureus peptidoglycan in patients with staphylococcal infections.
Topics: Adolescent; Adult; Antibodies, Bacterial; Child; Child, Preschool; Endocarditis, Bacterial; Furunculosis; Humans; Immunoglobulin G; Infant; Middle Aged; Osteomyelitis; Peptidoglycan; Radioimmunoassay; Sepsis; Staphylococcal Infections; Staphylococcus aureus | 1983 |
Antibacterial activity and mechanism of action of phosphonopeptides based on aminomethylphosphonic acid.
Topics: Animals; Anti-Bacterial Agents; Bacteria; Bacterial Proteins; Cell Wall; Drug Synergism; Escherichia coli; Female; Mice; Microbial Sensitivity Tests; Organophosphorus Compounds; Peptidoglycan; Phosphopeptides; Sepsis; Uridine | 1982 |
Role of peptidoglycan from Staphylococcus aureus in leukopenia, thrombocytopenia, and complement activation associated with bacteremia.
Topics: Animals; Complement Activation; Complement Pathway, Alternative; Guinea Pigs; Hematologic Diseases; Leukopenia; Peptidoglycan; Sepsis; Staphylococcal Infections; Staphylococcus aureus; Thrombocytopenia | 1982 |
Antibody levels to bacterial peptidoglycan in human sera during the time course of endocarditis and bacteremic infections caused by Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Antibodies, Bacterial; Antigen-Antibody Reactions; Endocarditis, Bacterial; Humans; Peptides; Peptidoglycan; Sepsis; Staphylococcal Infections | 1981 |
Synergistic septicemic action of the gram-positive bacterial cell wall components peptidoglycan and lipoteichoic acid in the pig in vivo.
Topics: Animals; Drug Synergism; Endothelin-1; Endotoxins; Female; Hydrocortisone; Interleukin-8; Leukocyte Count; Lipopolysaccharides; Lung Compliance; Male; Metyrapone; Nitric Oxide; Oxygen; Peptidoglycan; Pulmonary Circulation; Sepsis; Shock, Septic; Specific Pathogen-Free Organisms; Streptococcus pyogenes; Swine; Teichoic Acids; Tumor Necrosis Factor-alpha; Vascular Resistance | 2000 |
Peptidoglycan primes for LPS-induced release of proinflammatory cytokines in whole human blood.
Topics: Cytokines; Humans; Inflammation; Interleukin-10; Interleukin-6; Lipopolysaccharide Receptors; Lipopolysaccharides; Peptidoglycan; Sepsis; Tumor Necrosis Factor-alpha | 2001 |
Bacterial peptidoglycan-associated lipoprotein is released into the bloodstream in gram-negative sepsis and causes inflammation and death in mice.
Topics: Animals; Bacterial Outer Membrane Proteins; Cytokines; Dose-Response Relationship, Drug; Escherichia coli; Escherichia coli Proteins; Galactosamine; Gram-Negative Bacteria; Inflammation; Interleukin-1; Interleukin-6; Lipoproteins; Macrophages; Mice; Mice, Inbred C3H; Mutation; Myocardium; Nitrites; Peptidoglycan; Proteoglycans; Sepsis; Spleen; Time Factors; Tumor Necrosis Factor-alpha | 2002 |
Disseminated intravascular coagulation associated with Staphylococcus aureus septicemia is mediated by peptidoglycan-induced platelet aggregation.
Topics: Animals; Cell Wall; Complement C4; Disseminated Intravascular Coagulation; Guinea Pigs; Humans; Male; Peptidoglycan; Platelet Aggregation; Sepsis; Staphylococcal Infections; Staphylococcus aureus; Teichoic Acids | 1991 |
Serological assays against Staphylococcus aureus peptidoglycan, crude staphylococcal antigen and staphylolysin in the diagnosis of serious S. aureus infections.
Topics: Adolescent; Adult; Aged; Antibodies, Bacterial; Antigens, Bacterial; Cross Reactions; Endocarditis, Bacterial; Endotoxins; Enzyme-Linked Immunosorbent Assay; Female; Humans; Immunodiffusion; Immunoglobulin G; Male; Middle Aged; Peptidoglycan; Sepsis; Staphylococcal Infections; Staphylococcus aureus; Time Factors | 1985 |
Distinguishing complicated from uncomplicated bacteremia caused by Staphylococcus aureus: the value of "new" and "old" serological tests.
Topics: Antibodies, Bacterial; Antibody Formation; Antibody Specificity; Antigens, Bacterial; Bacterial Toxins; Endocarditis, Bacterial; Hemolysin Proteins; Humans; Peptidoglycan; Prognosis; Sepsis; Staphylococcal Infections; Staphylococcus aureus; Teichoic Acids | 1986 |